Continuous Glucose Monitoring–Derived Metrics and Cardiovascular Risk Among People With Diabetes: Systematic Scoping Review
Authors:
Open Access
- 6 May 2026
- journal article
- review article
- Published by JMIR Publications Inc. in JMIR Diabetes
- Vol. 11, e89374
Abstract
Background: Conventional clinical markers guide cardiovascular risk stratification; however, continuous glucose monitoring (CGM) data remain absent from prediction models. A synthesis of the current literature is needed to clarify the prognostic relevance of CGM data for cardiovascular outcomes in people with diabetes. Objective: This scoping review aimed to identify published studies examining (1) the associations between glycemic control and cardiovascular outcomes and (2) the predictive value of CGM-derived metrics in cardiovascular risk assessment. Methods: MEDLINE and Embase were searched from inception to March 11, 2025, for peer-reviewed, original research that included CGM-derived metrics and cardiovascular disease (CVD) outcomes. Two reviewers screened the records independently. Results: A total of 53 studies were identified. These studies focused on type 1 diabetes, type 2 diabetes, both diabetes types, or prediabetes. Clinical outcomes were examined in 16 studies, while subclinical outcomes were assessed in 40 studies. Of the 53 studies, 47 were cross-sectional studies and 6 were longitudinal studies. All studies were association studies, and 3 included secondary analyses of predictive performance. However, none applied machine learning–based methods. A wide range of CGM-derived metrics and CVD outcomes, both clinical and subclinical, were studied in the literature. Conclusions: Overall, the findings were inconsistent across studies, and this was likely due to methodological weaknesses such as underpowered analyses. Time-in-range was both the most studied metric and associated with cardiovascular risk in the largest single study. Only the mean amplitude of glycemic excursions was consistently associated with CVD in most studies investigating this metric, when using statistical significance as a pragmatic indicator of consistency across heterogeneous studies. The prognostic value of CGM-derived metrics for CVD outcomes is currently underexplored. Longitudinal prediction studies on clinical CVD outcomes, leveraging the potential of routinely collected CGM data, are needed.Keywords
This publication has 63 references indexed in Scilit:
- The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world studyDiabetologia, 2024
- Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complicationsActa Diabetologica, 2024
- Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetesDiabetologia, 2023
- Interaction between haptoglobin genotype and glycemic variability on diabetic macroangiopathy: a population-based cross-sectional studyEndocrine, 2023
- Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technologyAmerican Journal of Preventive Cardiology, 2022
- Citationchaser: A tool for transparent and efficient forward and backward citation chasing in systematic searchingResearch Synthesis Methods, 2022
- Greater daily glucose variability and lower time in range assessed with continuous glucose monitoring are associated with greater aortic stiffness: The Maastricht StudyDiabetologia, 2021
- Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1cClinica Chimica Acta, 2016
- HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) studyDiabetologia, 2010
- Glucose variability, blood pressure and arterial stiffness in type 1 diabetesDiabetes Research and Clinical Practice, 2008